Las Vegas Sands Corp. (BMV:LVS)

Oncternal Therapeutics Revenue

Las Vegas Sands had revenue of $3.18B USD in the quarter ending June 30, 2025, with 14.99% growth. This brings the company's revenue in the last twelve months to $11.62B, up 1.62% year-over-year. In the year 2024, Las Vegas Sands had annual revenue of $11.30B with 8.93% growth.

• Revenue (ttm): $11.62B
• Revenue Growth: +1.62%
• P/S Ratio: 3.10
• Revenue / Employee: $288.21K
• Employees: 40,300
• Market Cap: 679.63B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	11.30B	926.00M	8.93%
Dec 31, 2023	10.37B	6.26B	152.36%
Dec 31, 2022	4.11B	-124.00M	-2.93%
Dec 31, 2021	4.23B	1.29B	44.01%
Dec 31, 2020	2.94B	-9.19B	-75.76%